JP2677949B2 - Health food containing arachidonic acid - Google Patents
Health food containing arachidonic acidInfo
- Publication number
- JP2677949B2 JP2677949B2 JP5211357A JP21135793A JP2677949B2 JP 2677949 B2 JP2677949 B2 JP 2677949B2 JP 5211357 A JP5211357 A JP 5211357A JP 21135793 A JP21135793 A JP 21135793A JP 2677949 B2 JP2677949 B2 JP 2677949B2
- Authority
- JP
- Japan
- Prior art keywords
- arachidonic acid
- acid
- health food
- oil
- oils
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、比較的多量のアラキド
ン酸を含有する油脂、ドコサヘキサエン酸含有油脂およ
びカキ肉エキスを必須成分として配合し、良好な体調の
保持、体調改善などに有効な健康食品に関する。[Field of Industrial Application] The present invention contains fats and oils containing a relatively large amount of arachidonic acid, docosahexaenoic acid-containing fats and oils and oyster meat extract as essential components, and maintains good physical condition and improves physical condition. Regarding food.
【0002】[0002]
【従来の技術】アラキドン酸はプロスタグランディンの
生物学的前駆体であり、最近、その薬理効果が注目され
ている。アラキドン酸は、生体内では、リノール酸か
ら、γ−リノレン酸、ジホモ-γ-リノレン酸を経て合成
されるが、この合成アラキドン酸がプロスタグランジン
に変換され、これが効果を発揮するものと考えられてい
る。したがって、アラキドン酸やその生合成原料たるリ
ノール酸を医薬や、健康食品の有効成分とすることが提
案されている。例えば、特開昭59−62522号に
は、リノール酸やアラキドン酸を界面活性剤と共に水溶
性の組成物として経口投与し、消化器系障害の予防や治
療に用いることが提案されている。2. Description of the Related Art Arachidonic acid is a biological precursor of prostaglandin, and its pharmacological effect has recently attracted attention. Arachidonic acid is synthesized in vivo from linoleic acid via γ-linolenic acid and dihomo-γ-linolenic acid, and this synthetic arachidonic acid is converted to prostaglandins, which is considered to exert its effect. Has been. Therefore, it has been proposed to use arachidonic acid or linoleic acid, which is a biosynthetic raw material thereof, as an active ingredient of medicines and health foods. For example, JP-A-59-62522 proposes that linoleic acid and arachidonic acid are orally administered together with a surfactant as a water-soluble composition and used for the prevention and treatment of digestive system disorders.
【0003】しかし、リノール酸は通常の油脂食品中に
多量に含有されており、その入手は容易で、食物として
の摂取によって所望の効果を期待できるものの、アラキ
ドン酸は魚や肉、卵等の食品に少量含有されているにす
ぎず、その薬理効果を期待できる十分な量を安価に入手
することは困難である。また、特開昭59−62522
号では、精製された遊離脂肪酸形態のアラキドン酸を使
用しているが、これは高価であるので、実用的ではな
い。However, linoleic acid is contained in a large amount in ordinary fat and oil foods, and although it is easily available and a desired effect can be expected by ingestion as food, arachidonic acid is food such as fish, meat and eggs. It is contained only in a small amount, and it is difficult to inexpensively obtain a sufficient amount to expect its pharmacological effect. In addition, JP-A-59-62522
No. 6,068,047 uses purified free fatty acid form of arachidonic acid, which is not practical because it is expensive.
【0004】[0004]
【発明が解決しようとする課題】このような事情に鑑
み、本発明者らはアラキドン酸を用いた実用的な健康食
品を得るべく鋭意研究を行った結果、例えば、特開昭6
3−44891号や特開平2−86789号等に開示さ
れるような微生物学的方法により得られる高濃度のアラ
キドン酸を含有する油脂がその目的に好適であり、その
ような油脂を配合した健康食品が実用的であり、その摂
取が、良好な体調に維持や、体調の改善等に有用である
ことを見い出し、本発明を完成するに至った。In view of such circumstances, the present inventors have conducted earnest research to obtain a practical health food using arachidonic acid, and as a result, for example, Japanese Patent Laid-Open No.
Oils and fats containing a high concentration of arachidonic acid obtained by the microbiological method as disclosed in JP-A-3-44891 and JP-A-2-86789 are suitable for that purpose, and health containing such oils and fats is suitable. The present invention has been completed by finding that foods are practical and that their intake is useful for maintaining a good physical condition, improving physical condition, and the like.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明は、ア
ラキドン酸含有量が2重量%の油脂、ドコサヘキサエン
酸含有油脂およびカキ肉エキスを含有し、該ドコサヘキ
サエン酸の含有量が該アラキドン酸の含有量に対して
0.5〜7倍であることを特徴とする健康食品を提供す
るものである。Means for Solving the Problems That is, the present invention comprises an oil and fat having an arachidonic acid content of 2% by weight, an oil and fat containing docosahexaenoic acid, and an oyster meat extract, wherein the content of the docosahexaenoic acid is the content of the arachidonic acid. The present invention provides a health food characterized by being 0.5 to 7 times the amount.
【0006】天然に存在する油脂の中に、アラキドン酸
含有量が2重量%に達するものは見当たらないので、本
発明では、アラキドン酸生産能を有する微生物から得ら
れる油脂であって、アラキドン酸含有量が2重量%以
上、好ましくは10〜99重量%、さらに好ましくは2
0〜99重量%の油脂を必須成分として配合する。アラ
キドン酸の量が少なすぎると、その配合効果が期待でき
ないので、かかる油脂は本発明の組成物中のアラキドン
酸含有量が、組成物全体に対して2重量%以上、好まし
くは10重量%以上となるように配合する。[0006] Since no arachidonic acid content of 2% by weight is found among naturally occurring fats and oils, the present invention relates to a fat or oil obtained from a microorganism having an arachidonic acid-producing ability. The amount is 2% by weight or more, preferably 10 to 99% by weight, more preferably 2
0 to 99% by weight of fats and oils is added as an essential component. If the amount of arachidonic acid is too small, the compounding effect cannot be expected, so that the content of arachidonic acid in the composition of the present invention is 2% by weight or more, preferably 10% by weight or more based on the entire composition. Blend so that
【0007】このような比較的高濃度のアラキドン酸を
含有する油脂は、例えば、特開昭63−44891号に
開示の方法に従い、モルティエレラ(Mortiere
lla)属に属するアラキドン酸生産菌を、炭素源とし
てグルコース、窒素源として酵母エキスを用い、好まし
くは大豆油の存在下で培養し、アラキドン酸含有画分を
抽出、濃縮することにより、得ることができる。また、
特開平2−86789号に開示の方法に従い、エントモ
フトラ(Entomophthora)属糸状菌を、有
機多塩基酸を添加した培地中で培養することにより、ア
ラキドン酸を菌体内に高濃度で蓄積させ、これを採取す
ることにより、迅速かつ安価に大量生産することもでき
る。Such fats and oils containing a relatively high concentration of arachidonic acid can be prepared by, for example, the method disclosed in JP-A-63-44891.
an arachidonic acid-producing bacterium belonging to the genus lla), which is obtained by culturing in the presence of soybean oil, preferably using glucose extract as a carbon source and yeast extract as a nitrogen source, and extracting and concentrating an arachidonic acid-containing fraction. You can Also,
According to the method disclosed in Japanese Patent Application Laid-Open No. 2-86789, filamentous fungus of the genus Entomophthora is cultivated in a medium to which an organic polybasic acid is added to accumulate arachidonic acid at a high concentration in the microbial cells. By collecting, it can be mass-produced quickly and inexpensively.
【0008】本発明の健康食品は、かかる比較的高濃度
のアラキドン酸含有油脂、ドコサヘキサエン酸(以下、
DHAという)含有油脂およびカキ肉エキスを配合し、
その他に、エイコサペンタエン酸(以下、EPAとい
う)、γ−リノレン酸、α−リノレン酸、リノール酸、
これらの酸を含有する油脂、例えば、大豆油、ゴマ油、
精製魚油等、また、d−α−トコフェロール等のビタミ
ン、アミノ酸、食酢、食塩、甘味料、香辛料等の調味料
等を適宜配合させてもよい。The health food of the present invention comprises a arachidonic acid-containing oil and fat, docosahexaenoic acid (hereinafter,
DHA) containing fats and oils and oyster meat extract,
In addition, eicosapentaenoic acid (hereinafter referred to as EPA), γ-linolenic acid, α-linolenic acid, linoleic acid,
Fats and oils containing these acids, for example, soybean oil, sesame oil,
Purified fish oil and the like, vitamins such as d-α-tocopherol, amino acids, vinegar, salt, sweeteners, seasonings such as spices and the like may be appropriately mixed.
【0009】特に、アラキドン酸と共に、DHAを含有
させることにより、アラキドン酸の体内での働きが促進
され、その健康食品としての効用がさらに向上すること
が判明した。一般に、DHAは、アラキドン酸に対する
重量比で、0.5〜7倍の割合で添加すると所望の促進
効果が得られる。In particular, it has been found that the inclusion of DHA together with arachidonic acid promotes the action of arachidonic acid in the body and further improves its effect as a health food. Generally, when DHA is added in a weight ratio of 0.5 to 7 times with respect to arachidonic acid, a desired promoting effect is obtained.
【0010】また、アラキドン酸と共に、カキ肉エキス
を含有させることにより、脂肪酸とアミノ酸の両方を摂
取することができ、健康食品そして、より一層の効用を
期待できる。一般に、カキ肉エキスは、アラキドン酸に
対する重量比で、2〜150倍、好ましくは15〜50
倍の割合で添加すると所望の効果が得られる。Further, by incorporating oyster meat extract together with arachidonic acid, both fatty acid and amino acid can be ingested, and health food and further effects can be expected. Generally, the oyster meat extract has a weight ratio to arachidonic acid of 2 to 150 times, preferably 15 to 50 times.
The desired effect is obtained when added in a doubled ratio.
【0011】本発明の健康食品は、常法により、油剤、
エマルジョン、ソフトカプセル剤、ハードカプセル剤、
錠剤、顆粒剤、固形剤、チュアブル剤、ドレッシング
類、菓子類等の形態にすることができる。また、本発明
の健康食品は、人に限らず、イヌ、ネコ、ラット、ネズ
ミ、モルモット、サル、ヒヒ等の哺乳動物の飼料として
もよく、例えば、常法に従い、飼料用の固体または液体
の添加剤とすることもできる。かかる、飼料も本発明の
健康食品に包含する。The health food of the present invention comprises an oil solution,
Emulsion, soft capsule, hard capsule,
It can be in the form of tablets, granules, solids, chewables, dressings, confectionery and the like. The health food of the present invention is not limited to humans, but may be feed for mammals such as dogs, cats, rats, rats, guinea pigs, monkeys, and baboons. For example, according to a conventional method, a solid or liquid feed is used. It can also be an additive. Such feeds are also included in the health food of the present invention.
【0012】本発明の健康食品は、通常、アラキドン酸
の1日の摂取量が成人の場合、50〜2000mg/
日、好ましくは200〜500mg/日となるように使
用する。また、人以外の哺乳動物については、アラキド
ン酸の1日の摂取量が1〜50mg/kg、好ましくは
5〜10mg/kgとなるように与える。これにより、
疲労回復、美容、便秘改善や、神経痛、腰痛、肩凝りの
改善等が図れる。The health food of the present invention is usually 50 to 2000 mg / day when the daily intake of arachidonic acid is an adult.
The daily dose is preferably 200 to 500 mg / day. For mammals other than humans, the daily intake of arachidonic acid is 1 to 50 mg / kg, preferably 5 to 10 mg / kg. This allows
It can improve fatigue, beauty, constipation, neuralgia, back pain, and stiff shoulder.
【0013】[0013]
【実施例】以下に実施例および実験例を挙げて本発明を
さらに詳しく説明するが、本発明はこれらに限定される
ものではない。なお、実施例中の「%」は「重量%」を
意味する。The present invention will be described in more detail with reference to Examples and Experimental Examples, but the present invention is not limited thereto. In addition, "%" in an Example means "weight%."
【0014】実施例1 以下の処方により、常法に従って、ソフトカプセル剤を
製造した。 成 分 配合量 アラキドン酸含有油脂 50.0% (アラキドン酸を22%以上含有) エイコサペンタエン酸(EPA)含有精製魚油 18.5% (EPAを28%以上、DHAを12%以上含有) ドコサヘキサエン酸(DHA)含有精製魚油 30.0% (EPAを8%以上、DHAを30%以上含有) ビタミンE抽出液 1.5%Example 1 A soft capsule was manufactured according to a conventional method according to the following formulation. Ingredients Amount of arachidonic acid-containing oil 50.0% (containing 22% or more arachidonic acid) Purified fish oil containing eicosapentaenoic acid (EPA) 18.5% (containing 28% or more EPA and 12% or more DHA) docosahexaenoic acid (DHA) containing purified fish oil 30.0% (EPA containing 8% or more, DHA containing 30% or more) Vitamin E extract 1.5%
【0015】実施例2 以下の処方により、常法に従って、ドレッシングを製造
した。 Example 2 A dressing was produced according to a conventional method according to the following formulation.
【0016】実施例3 まず、以下の処方により、常法に従って、アラキドン酸
粉末を調製した。 Example 3 First, arachidonic acid powder was prepared according to a conventional method according to the following formulation.
【0017】アラキドン酸含有油脂を溶媒のエタノール
に溶解し、残りの原料を混合したものに、この溶液を添
加し、混合分散させて吸着させた後、加温乾燥して溶媒
を除去し、アラキドン酸粉末とした。こうして得られた
アラキドン酸粉末を用い、以下の処方により、常法に従
って、ハードカプセル剤を製造した。 Arachidonic acid-containing fats and oils were dissolved in ethanol as a solvent, and the remaining raw materials were mixed, and this solution was added, mixed and dispersed for adsorption, and then heated and dried to remove the solvent and arachidone. Acid powder was used. Using the arachidonic acid powder thus obtained, a hard capsule was manufactured according to a conventional method according to the following formulation.
【0018】実施例4 実施例3で調製したアラキドン酸粉末を用い、以下の処
方により、常法に従って、錠剤を製造した。 Example 4 Using the arachidonic acid powder prepared in Example 3, tablets were manufactured according to a conventional method according to the following formulation.
【0019】実験例 実施例1で得られたソフトカプセルを40才以上の男子
10人、女子20人に、1日6粒を数回に分け、食後に
服用させ、これを2カ月続け、体調改善、便秘改善、肌
の調子の変化、神経痛、腰痛、肩凝りの改善について主
観的な効果を報告させた。その結果、30人中12人
が、服用開始後約2週間から1カ月で、体調改善に有効
であると報告した。また、便秘改善については、30人
中10人が3日〜1カ月後に有効と、肌の調子について
は、30人中10人が1週間〜1カ月後に「よくなる」
と報告した。さらに、30人中8人が1カ月〜1.5月
後に神経痛、腰痛、肩凝りが楽になると報告した。Experimental Example The soft capsules obtained in Example 1 were given to 10 boys and 20 girls over 40 years old, 6 capsules per day, divided into several doses, taken after meals, and continued for 2 months to improve their physical condition. They reported subjective effects on improving constipation, skin tone changes, neuralgia, low back pain, and stiff shoulders. As a result, 12 out of 30 people reported that it was effective for improving physical condition about 2 weeks to 1 month after the start of taking the drug. In addition, 10 out of 30 were effective after 3 days to 1 month for improving constipation, and 10 out of 30 were “well” after 1 week to 1 month for skin tone.
I reported. In addition, 8 out of 30 people reported that neuralgia, low back pain, and stiff shoulders became easier after 1 month to 1.5 months.
【0020】[0020]
【発明の効果】本発明によれば、遊離脂肪酸形態のアラ
キドン酸ではなく、安価に大量生産可能なアラキドン酸
含有油脂、さらにDHA含有油脂およびカキ肉エキスを
含有する、アラキドン酸の体内での働きが促進され、よ
り効用の向上した健康食品が得られる。INDUSTRIAL APPLICABILITY According to the present invention, the action of arachidonic acid in the body containing arachidonic acid-containing fats and oils that can be mass-produced inexpensively, DHA-containing fats and oils and oyster meat extract, rather than arachidonic acid in the form of free fatty acids. Is promoted, and a health food with improved efficacy can be obtained.
Claims (4)
脂、ドコサヘキサエン酸含有油脂およびカキ肉エキスを
含有し、該ドコサヘキサエン酸の含有量が該アラキドン
酸の含有量に対して0.5〜7倍であることを特徴とす
る健康食品。1. An oil and fat having an arachidonic acid content of 2% by weight or more, an oil and fat containing docosahexaenoic acid, and an oyster meat extract, wherein the content of the docosahexaenoic acid is 0.5 to 7 with respect to the content of the arachidonic acid. Health food characterized by being doubled.
載の健康食品。2. The health food according to claim 1, which is in the form of soft capsules.
載の健康食品。3. The health food according to claim 1, which is in the form of a hard capsule.
品。4. The health food according to claim 1, which is in the form of a tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5211357A JP2677949B2 (en) | 1993-08-26 | 1993-08-26 | Health food containing arachidonic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5211357A JP2677949B2 (en) | 1993-08-26 | 1993-08-26 | Health food containing arachidonic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0759540A JPH0759540A (en) | 1995-03-07 |
JP2677949B2 true JP2677949B2 (en) | 1997-11-17 |
Family
ID=16604634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5211357A Expired - Fee Related JP2677949B2 (en) | 1993-08-26 | 1993-08-26 | Health food containing arachidonic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2677949B2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3792309B2 (en) | 1996-08-30 | 2006-07-05 | サントリー株式会社 | Process for producing unsaturated fatty acid-containing fats and oils |
PL335227A1 (en) * | 1997-02-20 | 2000-04-10 | Dsm Nv | Industrial-scale production of valuable compounds by fermentation in a chemically defined medium |
DE102005058369A1 (en) * | 2005-12-06 | 2007-06-14 | Lts Lohmann Therapie-Systeme Ag | Unsaturated fatty acids as thrombin inhibitors |
WO2007119378A1 (en) | 2006-03-15 | 2007-10-25 | Suntory Limited | Composition containing riboflavin and sesamins |
EP3342409A1 (en) | 2007-03-15 | 2018-07-04 | Suntory Holdings Limited | Anti-fatigue agent |
KR101528380B1 (en) | 2007-09-19 | 2015-06-11 | 산토리 홀딩스 가부시키가이샤 | Composition comprising sesamin component and arachidonic acid component |
JP2009073747A (en) * | 2007-09-19 | 2009-04-09 | Suntory Ltd | Anti-fatigue agent containing arachidonic acid as active ingredient |
CN116158433B (en) * | 2023-02-28 | 2024-03-15 | 浙江大学 | Population regulator for preventing and controlling soil termites as well as preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54154533A (en) * | 1978-05-26 | 1979-12-05 | Wellcome Found | Protecting and treating preparation of thrombsis |
JPS5962522A (en) * | 1982-08-09 | 1984-04-10 | ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア | Method and composition for protecting and treating gastric duodenal mucosa and lever |
JPH0286789A (en) * | 1988-09-24 | 1990-03-27 | Nippon Oil & Fats Co Ltd | Production of fats and oils containing arachidonic acid by microorganism |
-
1993
- 1993-08-26 JP JP5211357A patent/JP2677949B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54154533A (en) * | 1978-05-26 | 1979-12-05 | Wellcome Found | Protecting and treating preparation of thrombsis |
JPS5962522A (en) * | 1982-08-09 | 1984-04-10 | ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア | Method and composition for protecting and treating gastric duodenal mucosa and lever |
JPH0286789A (en) * | 1988-09-24 | 1990-03-27 | Nippon Oil & Fats Co Ltd | Production of fats and oils containing arachidonic acid by microorganism |
Also Published As
Publication number | Publication date |
---|---|
JPH0759540A (en) | 1995-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI285549B (en) | Therapeutic combinations of fatty acids | |
AU618814B2 (en) | Essential fatty acid compositions | |
TWI358292B (en) | Composition with effects of decline prevention, im | |
TW323230B (en) | ||
CA2260265C (en) | Novel use of phospholipids of animal origin in therapy and/or dietetics | |
US20090099261A1 (en) | Omega-3 mixtures | |
DE10102050A1 (en) | Food, nutritional supplement, feed or medicament preparations containing conjugated cis/trans-octatrienoic acid, useful e.g. for reducing food intake, improving food utilization or treating cancer or diabetes | |
JP2574153B2 (en) | Drugs for cancer treatment | |
TWI389697B (en) | Improve the composition of lipid metabolism | |
JP2001031566A (en) | Inhibitory composition for problematic behavior of pet | |
JP2677949B2 (en) | Health food containing arachidonic acid | |
DE69523759T2 (en) | PREPARATIONS OF NERVONIC ACID | |
TW200522939A (en) | Composition having action preventing or alleviating symptoms or diseases due to aging of blood vessels | |
JPH10500937A (en) | Anti-inflammatory and protective effects of sesaminic lignans | |
JPH0336493B2 (en) | ||
JP2941787B2 (en) | Pharmaceutical composition and health food containing polyunsaturated fatty acid | |
JPH06271464A (en) | Arachidonic acid-containing composition for prevention or improvement of alimentary disorder | |
JP3947322B2 (en) | Pharmaceutical composition and health food containing polyunsaturated fatty acid | |
JPH05163142A (en) | Arachidonic acid-containing composition for preventing and treating liver disease | |
JP2000302677A (en) | Medicine and food/feed composition having improving action on carnitine self production ability | |
CN118414093A (en) | Oral compositions and methods for inhibiting bitter taste from ergothioneine or salt thereof and odor from eicosapentaenoic acid | |
CN118434299A (en) | Oral compositions and methods for inhibiting bitter taste from ergothioneine or salt thereof and malodor from arachidonic acid | |
JP2009084244A (en) | Skin barrier function improving agent and the like | |
JP2000086425A (en) | Skin-whitening agent and skin whitening composition containing the same | |
JP2009073747A (en) | Anti-fatigue agent containing arachidonic acid as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19970617 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080725 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080725 Year of fee payment: 11 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090725 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090725 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100725 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110725 Year of fee payment: 14 |
|
LAPS | Cancellation because of no payment of annual fees |